Ophthalmology Science Publishes First Peer-Reviewed Multi-Vendor AI-DR Implementation Playbook (LumineticsCore + EyeArt + AEYE-DS)

Ophthalmology Science published a peer-reviewed implementation study aggregating real-world adoption of LumineticsCore, EyeArt, and AEYE-DS across US health systems. Aggregate nonmydriatic gradability 49-75%, sensitivity 87-100%, specificity 60-91%. Identifies FQHCs as ideal deployment sites because FQHC patients are less likely to access traditional eye-doctor screening. Success factors: site selection, primary-care workflow alignment, patient engagement/referral streamlining, ongoing staff training. Strategic implication: first peer-reviewed multi-vendor implementation playbook for AI-DR in primary care. Directly transferable to CA FQHC operations directors evaluating which of the 3 FDA-cleared systems to deploy, what gradability/sensitivity to expect in an MA-operated workflow, and the 4 success factors to plan around. Strengthens AI Tracker entries already in our database on LumineticsCore/EyeArt/AEYE-DS with peer-reviewed cross-vendor benchmarks rather than vendor-supplied stats.